Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma

Also known as: Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma

Drug	Drug Name	Drug Description
DB12240	Polatuzumab vedotin	A CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma.

Drug	Drug Name	Target	Type
DB12240	Polatuzumab vedotin	Cytochrome P450 3A4	enzyme
DB12240	Polatuzumab vedotin	B-cell antigen receptor complex-associated protein beta chain	target
DB12240	Polatuzumab vedotin	P-glycoprotein 1	transporter
DB12240	Polatuzumab vedotin	Cytochrome P450 3A5	enzyme

Drug	Drug Name	Phase	Status	Count
DB00531	Cyclophosphamide	2	Completed	1
DB00531	Cyclophosphamide	2	Recruiting	1
DB00997	Doxorubicin	2	Completed	1
DB01073	Fludarabine	2	Recruiting	1
DB09053	Ibrutinib	2	Completed	1
DB09037	Pembrolizumab	2	Recruiting	1
DB00860	Prednisolone	2	Completed	1
DB00073	Rituximab	2	Completed	1
DB00541	Vincristine	2	Completed	1